Dr Wonkam’s vision for 3MAG, as outlined in Nature, a scientific journal, is for 300,000 African genomes to be sequenced per year over a decade.That is the minimum needed to capture the continent’s diversity.He notes that the UK biobank is sequencing 500,000 genomes, though Britain’s population is a twentieth the size of Africa’s.The plummeting cost of technology makes 3MAG possible.Sequencing the first genome cost $300m; today the cost of sequencing is around $1,000.If data from people of African descent in similar projects, like the UK biobank, were shared with 3MAG, that would help.So too would collaboration with genetics firms, such as 54Gene, a Nigerian start-up.The 3MAG project is building on firm foundations.Over the past decade the Human Heredity and Health in Africa consortium, sponsored by America’s National Institutes of Health and the Wellcome Trust, a British charity, has supported research institutes in 30 African countries.It has funded local laboratories for world-class scientists such as Dr Wonkam and Christian Happi, a Nigerian geneticist.There are practical issues to iron out.One is figuring out how to store the vast amounts of data.Another is rules around consent and data use, especially if 3MAG will involve firms understandably keen to commercialise the findings.
旺坎博士在科学杂志《自然》上概述了对3MAG的设想，即在未来十年内，每年要对30万个非洲基因组进行测序。这是捕捉非洲大陆多样性所需的最低限度。他指出，英国生物库正在对50万个基因组进行测序，尽管英国的人口是非洲的二十分之一。技术成本的急剧下降使3MAG的开展成为可能。第一个基因组的测序花费了3亿美元；如今测序的成本约为1000美元。如果类似项目（英国生物库）中的非洲人后裔的数据能与3MAG共享，那将有所帮助。与基因公司的合作也是如此，比如尼日利亚初创公司54Gene。3MAG项目正在坚实的基础上开展着。在过去的十年里，由美国国立卫生研究院和英国慈善机构惠康信托基金会赞助的“非洲人类健康与遗传新方案协会”为30个非洲国家的研究机构提供了支持。它为旺坎博士和尼日利亚遗传学家克里斯蒂安・哈皮等世界级科学家所在的当地实验室提供了资金支持。有一些实际问题需要解决。一个问题是找出存储大量数据的方式。另一个是关于同意和数据使用的规则，特别是如果3MAG让热衷于将研究结果商业化的公司（这是可以理解的）参与进来。
暂无注释
